Clinical Trials Directory

Trials / Completed

CompletedNCT05560568

Effects of Optimizing Nocturnal Glycemic Control on Sleep Parameters in Type 1 Diabetes

Status
Completed
Phase
Study type
Observational
Enrollment
18 (actual)
Sponsor
Hospices Civils de Lyon · Academic / Other
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Not accepted

Summary

Sleep is crucial for physical and mental health. Environmental, social, or professional pressures can cause sleep duration to fall below the recommended 7-9 hours of sleep per night. Young adults with type 1 diabetes, have additional interference with fear, control and management of hypo/hyperglycemia management, alarms from their devices, which delay bedtime, disrupt sleep and generate multiple awakenings and difficulty returning to sleep. Sleep disturbance is correlated with blood glucose variability as recently demonstrated by a coupled analysis of sleep and glucose level collected by Continuous Glucose Monitoring (CGM). In this study, higher glucose variability predicted impaired sleep at the individual level. Automated insulin infusion has shown impressive results in clinical and real-life studies, with more than 90% of patients achieving good glycemic control. Il seems to improve sleep quality in subjects after 4 weeks in hybrid closed-loop, self-administered studies compared to a control group. The main objective of our study is to measure the positive influence of a better glycemic control on the different sleep parameters in subjects with type 1 diabetes at the time of the passage in hybrid closed-loop and in comparison to an identical period in open-loop.

Conditions

Interventions

TypeNameDescription
OTHERSleep parameters data collectionSleep parameters collected before and after hybrid close-loop pump activation. Data collected with adequate devices (i.e. actigraph and Dreem Band).

Timeline

Start date
2023-01-20
Primary completion
2024-06-13
Completion
2024-06-13
First posted
2022-09-29
Last updated
2024-08-07

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05560568. Inclusion in this directory is not an endorsement.